Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech
Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech
Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech
Submitted by
admin
on November 15, 2017 - 11:06am
Source:
Endpoints
News Tags:
Sangamo
gene editing
Hunter Syndrome
CRISPR
SB-913
Headline:
Sangamo claims a major milestone in gene editing, treating first patient with its zinc finger nuclease tech
Do Not Allow Advertisers to Use My Personal information
